ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

MORF Morphic Holding Inc

26.98
-0.77 (-2.77%)
Fuera de horario
Última actualización: 15:43:27
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Morphic Holding Inc MORF NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.77 -2.77% 26.98 15:43:27
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
27.26 26.00 27.26 26.45 27.75
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/6/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202415:41EDGAR2Form 8-K - Current report
31/5/202407:00GLOBEMorphic to Participate in Jefferies Global Healthcare..
21/5/202407:00GLOBEMorphic Demonstrates Novel Real-Time Visualization of Small..
09/5/202415:05GLOBEMorphic to Participate in RBC Capital Markets Global..
25/4/202406:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
19/3/202407:00GLOBEMorphic Appoints Dr. Simon Cooper as Chief Medical Officer
05/3/202415:05GLOBEMorphic to Participate in March Investor Conferences
22/2/202406:46EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202406:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202406:04EDGAR2Form 8-K - Current report
22/2/202406:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
17/1/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:08EDGAR2Form 8-K - Current report
03/1/202415:05GLOBEMorphic to Present at the 42nd Annual J.P. Morgan Healthcare..
06/12/202307:57EDGAR2Form 8-K - Current report
10/11/202307:00GLOBEMorphic to Present at November Investor Conferences
03/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202306:13EDGAR2Form 8-K - Current report
03/11/202306:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
12/10/202307:52EDGAR2Form 8-K - Current report
09/10/202307:00GLOBEMorphic Therapeutic to Host Webcast to Present EMERALD-1..
26/9/202316:30EDGAR2Form 8-K - Current report
26/9/202315:10GLOBEMorphic Holdings Announces CEO Dr. Praveen Tipirneni to Take..
22/9/202316:30GLOBEMorphic to Present Positive EMERALD-1 Phase 2a Data for..
08/9/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202315:24EDGAR2Form 144 - Report of proposed sale of securities
29/8/202307:00GLOBEMorphic Announces Participation in 2023 Wells Fargo..
09/8/202315:05GLOBEMorphic to Present at the Canaccord Genuity 43rd Annual..
03/8/202317:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202306:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202306:08EDGAR2Form 8-K - Current report
03/8/202306:05GLOBEMorphic Announces Corporate Highlights and Financial Results..
06/7/202318:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

Delayed Upgrade Clock